Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Glycyl-glutamine suppresses nicotine addiction in rats

Feb. 17, 2006

Gabapentin effects differ in studies of alcohol withdrawal and cocaine dependence

Feb. 8, 2006

Nicotine addiction vaccine surpasses target antibody level in dose-optimization study

Feb. 6, 2006

NicVAX completes phase II dose-ranging study, set for proof-of-concept trial

Jan. 30, 2006

Manufacturing milestone in RiVax development

Jan. 27, 2006

Approvable letter for Vivitrol

Dec. 30, 2005

Priority review for varenicline tartrate in smoking cessation

Dec. 23, 2005

N-Acetylcysteine shown to decrease craving in hospitalized cocaine addicts

Dec. 20, 2005

Antalarmin lacks efficacy in primate models of cocaine self-administration and discrimination

Dec. 19, 2005

Varenicline, an effective and safe treatment for smoking cessation

Nov. 29, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...